Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026)

Odyssey Health's (ODYY) quarterly Liabilities and Shareholders Equity came in at $373779.0 in Q2 2026, up 127.21% year-on-year from $164508.0 in Q2 2025, and down 48.18% quarter-over-quarter from $721304.0 in Q1 2026.

Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Odyssey Health's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $373779.0 for Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 127.21% year-over-year to $373779.0 in Q2 2026; TTM through Apr 2026 was $1.3 million, a 5.16% decrease from a year earlier, with the FY2025 full-year figure at $49723.0, down 91.52% from the prior year.
  • Liabilities and Shareholders Equity declined to $373779.0 in Q2 2026 per ODYY's latest filing, from $721304.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $14.0 million in Q1 2024 and bottomed at $49723.0 in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $459620.0 (2023), against an average of $1.9 million.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 3014.39% in 2024 and plunged 98.79% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $867723.0 in 2022, then declined by 29.47% to $612039.0 in 2023, then slumped by 44.28% to $341045.0 in 2024, then tumbled by 57.89% to $143622.0 in 2025, then surged by 160.25% to $373779.0 in 2026.
  • Per Business Quant, the three latest ODYY Liabilities and Shareholders Equity figures stand at $373779.0 (Q2 2026), $721304.0 (Q1 2026), and $143622.0 (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Odyssey Health 1.08 Mn 782,508.17 - 373,779.00

Historic Data

Download Data
DateValue
Apr 30, 2026 373,779.00
Jan 31, 2026 721,304.00
Oct 31, 2025 143,622.00
Jul 31, 2025 49,723.00
Apr 30, 2025 164,508.00
Jan 31, 2025 266,866.00
Oct 31, 2024 341,045.00
Jul 31, 2024 586,146.00
Apr 30, 2024 13.58 Mn
Jan 31, 2024 14.05 Mn
Oct 31, 2023 612,039.00
Jul 31, 2023 455,793.00
Apr 30, 2023 435,908.00
Jan 31, 2023 463,447.00
Oct 31, 2022 867,723.00
Jul 31, 2022 569,677.00
Apr 30, 2022 619,104.00
Jan 31, 2022 334,215.00
Oct 31, 2021 931,813.00
Jul 31, 2021 610,533.00